Usefulness of Handgrip Strength to Predict Mortality in Patients With Coronary Artery Disease - 24/07/20

, Christoph H. Saely, MD a, b, c, ⁎Highlights |
• | Handgrip strength predicts cardiovascular events and mortality in the general population. |
• | Patients with established coronary artery disease (CAD) are at a particularly high risk of cardiovascular events and mortality. |
• | The impact of handgrip strength on the prognosis of CAD patients has not been studied yet. |
• | Here, we show in a large cohort of patients with angiographically verified stable CAD that handgrip strength predicts cardiovascular events and mortality in patients with CAD, independently from classical cardiovascular risk factors. |
Résumé |
Handgrip strength (HGS) is a validated and simple technique to estimate skeletal muscular strength. Whether HGS is a predictor of overall mortality in patients with established coronary artery disease (CAD) is not known, this question is therefore addressed in the present study. We prospectively investigated a cohort of 691 patients with angiographically proven CAD. HGS was measured at baseline, and all-cause death as well as cardiovascular events was recorded over a period of up to 12 years. During a follow-up time of 9.2 ± 3.1 years, 31.3% (n = 216) of the study participants died. Further, 27.8% (n = 192) suffered major cardiovascular events and 56.6% (n = 391) any cardiovascular event. Cox proportional hazard model analysis showed a reduced mortality risk with higher HGS univariately (hazard ratio [HR] for each 5 kg increase in HGS 0.87 [95% confidence interval 0.82 to 0.92]; p <0.001), after adjustment for age and gender (HR 0.86 [0.79 to 0.94]; p = 0.001), and after further adjustment for conventional cardiovascular risk factors (HR 0.86 [0.79 to 0.94]; p = 0.001). Similarly, high HGS was protective of major cardiovascular events as well as of total cardiovascular events (HRs in the fully adjusted model 0.86 [0.78 to 0.94]; p = 0.002 and 0.89 [0.83 to 0.96]; p = 0.002, respectively). From these data, we conclude that HGS is an independent predictor of overall survival and of cardiovascular events in patients with CAD.
Le texte complet de cet article est disponible en PDF.Plan
| Funding: This work has been supported by the “Jubiläumsfonds” of the Austrian National Bank (project number 14159); the “Dr. Karl Josef Hier Stiftung”; the Institute for Clinical Chemistry at the Academic Teaching Hospital Feldkirch; and the “Land Vorarlberg.” These institutions did not have any role in the design of the study, data collection, analysis and interpretation nor in writing the manuscript. |
Vol 129
P. 5-9 - août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
